+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anesthesia & Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Anesthesia Devices, Respiratory Devices), By Region, And Segment Forecasts, 2019 - 2026

  • ID: 4773497
  • Report
  • 125 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Charts Industries
  • Drägerwerk AG & Co. KGaA
  • GE Healthcare
  • Getinge AB
  • Masimo Corporation
  • MORE
The global anesthesia and respiratory devices market size is expected to reach USD 49.4 billion by 2026, according to this new report. It is anticipated to expand at a CAGR of 6.6% over the forecast period. Increasing prevalence of respiratory diseases, patient preferences for reduced hospital stay, and supportive government funding are among the key driving factors.

Shifting preference of patients towards reduced hospital stay is anticipated to increase the adoption of anesthesia and breathing instruments, thereby, driving the market. As per the American Hospital Association, approximately 20% of Medicare beneficiaries, when discharged from hospital return within 30 days. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and reduce spending. Hence, policymakers are striving to reduce hospital stays of patients. The Patient Protection and Affordable Act, Congress initiated the Hospital Readmission Reduction Program (HRRP) under which Medicare is allowed to penalize hospitals for higher rates of readmissions since 2013. Due to the implementation of this act, many physicians and patients opt for anesthesia and breathing devices, such as ambulatory infusion pumps and home respiratory monitors.

Furthermore, aging is considered one of the greatest risk factors for the development of sleep apnea disorders and is therefore, expected to be a high-impact rendering driver for this market.

Key players are also taking initiatives to develop advanced instruments with an aim to bring improvement in the treatment. For instance, in April 2018, B. Braun Medical Inc. announced to introduce Clorotekal, which is a U.S. Food and Drug Administration (FDA) approved anesthetics for spinal anesthesia. Such initiatives are anticipated to propel growth of the anesthesia and respiratory devices market in the forthcoming years.

Further key findings from the study suggest:
  • On the basis of product, respiratory devices is estimated to expand at the highest CAGR in terms of revenue over the forecast period owing to rising prevalence of cystic fibrosis, asthma, and tuberculosis. Positive airway pressure devices led the segment owing to increasing incidence of Obstructive Sleep Apnea (OSA)
  • Asia Pacific is expected to witness the fastest growth over the forecast period owing to increasing healthcare expenditure and awareness among patients
  • Few key players operating in the anesthesia and respiratory devices market are AirSep Corporation; B. Braun Medical Inc.; BD; Medtronic; Drager; GE Healthcare; Philips Healthcare; ResMed; and Smiths Medical.

Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Charts Industries
  • Drägerwerk AG & Co. KGaA
  • GE Healthcare
  • Getinge AB
  • Masimo Corporation
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Information Procurement
1.2.1. Purchased database
1.2.2. Internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information Analysis
1.3.1. Data analysis models
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User Perspective Analysis
3.4.1. Consumer behavior analysis
3.4.2. Market influencer analysis
3.5. List of Key End-users, by Region/by Country/by Product
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & compliances
3.7. Market Dynamics
3.7.1. Market driver analysis
3.7.1.1. Shifting patient preference towards reduced hospital stay
3.7.1.2. Supportive government funding in emerging markets
3.7.1.3. Increasing global geriatric population base
3.7.1.4. Technological advancements
3.7.2. Market restraint analysis
3.7.2.1. Lack of patient compliance
3.7.2.2. Economic impact of respiratory disorders
3.7.3. Industry challenges
3.7.3.1.Harmful effects of the respiratory devices on neonates
3.8. Anesthesia and respiratory devices: Market Analysis Tools
3.8.1. Industry analysis - Porter’s
3.8.1.1. Supplier power: (Moderate): Presence of various major raw material suppliers
3.8.1.2. Buyer power: (Moderate): Existence of insurance agencies focusing on cost reduction is expected to result in the consolidation
3.8.1.3. Substitution threat: (Moderate): Introduction of technological advanced products
3.8.1.4. Threat from new entrant: (Moderate): Complying with various regulatory bodies
3.8.1.5. Competitive rivalry: (High): Dominated by few major players
3.8.2. PESTEL analysis
3.8.2.1 .Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major deals & strategic alliances analysis
3.8.3.1. Joint ventures
3.8.3.2. Mergers & acquisitions
3.8.3.3. Licensing & partnership
3.8.3.4. Technology collaborations
3.8.3.5. Strategic divestments
3.8.4. Market entry strategies

Chapter 4. Anesthesia and respiratory devices Market: Segment Analysis, By Product, 2015 - 2026 (USD Million)
4.1. Definitions & Scope
4.2. Product Market Share Analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Anesthesia and respiratory devices Market, by Product, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Anesthesia devices
4.5.1.1. Anesthesia machines
4.5.1.1.1. Anesthesia workstation
4.5.1.1.2. Anesthesia delivery machines
4.5.1.1.2.1. PorTable
4.5.1.1.2.2. Standalone
4.5.1.1.3. Anesthesia ventilators
4.5.1.1.4. Anesthesia monitors
4.5.1.2. Anesthesia disposables
4.5.1.2.1. Anesthesia masks
4.5.1.2.2. Anesthesia accessories
4.5.2. Respiratory devices
4.5.2.1. Respiratory equipment
4.5.2.1.1. Humidifiers
4.5.2.1.1.1. Heat humidifiers
4.5.2.1.1.2. Heated wire breathing circuits
4.5.2.1.1.3. Heat exchangers
4.5.2.1.1.4. Pass over humidifiers
4.5.2.1.2. Nebulizers
4.5.2.1.2.1. Pneumatic nebulizers
4.5.2.1.2.2. Mesh nebulizers
4.5.2.1.2.3. Ultrasonic nebulizers
4.5.2.1.3. Oxygen concentrator
4.5.2.1.3.1. Fixed oxygen concentrators
4.5.2.1.3.2. PorTable oxygen concentrators
4.5.2.1.4. Positive airway pressure devices
4.5.2.1.4.1. Bi-level positive airway pressure devices
4.5.2.1.4.2. Continuous positive airway pressure devices
4.5.2.1.5. Reusable resuscitators
4.5.2.1.6. Ventilators
4.5.2.1.6.1. Adult ventilators
4.5.2.1.6.2. Neonatal ventilators
4.5.2.1.7. Respiratory inhalers
4.5.2.1.7.1. Dry powdered inhaler
4.5.2.1.7.2. Metered dose inhaler
4.5.2.2. Respiratory disposables
4.5.2.2.1. Disposable oxygen masks
4.5.2.2.2. Resuscitators
4.5.2.2.3. Tracheotomy Tubes
4.5.2.2.4. Oxygen Cannula
4.5.2.3. Respiratory measurement devices
4.5.2.3.1. Pulse oximetry systems
4.5.2.3.2. Capnographs
4.5.2.3.3. Spirometers
4.5.2.3.4. Peak flowmeters

Chapter 5. Anesthesia and Respiratory Devices Market: Regional Market Analysis, By Region, 2015 - 2026 (USD Million)
5.1. Definitions & Scope
5.2. Regional Market Share Analysis, 2018 & 2026
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.5. Regional Market Share and Leading Players, 2018
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
5.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
5.7. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025:
5.8. North America
5.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.8.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.8.3. U.S.
5.8.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.8.4. Canada
5.8.4.1.Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9. Europe
5.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.9.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.3. Germany
5.9.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.4. U.K.
5.9.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.5. Italy
5.9.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.6. France
5.9.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.9.7. Spain
5.9.7.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10. Asia Pacific
5.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.10.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.3. India
5.10.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.4. China
5.10.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.5. Japan
5.10.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.6. Australia
5.10.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.10.7. South Korea
5.10.7.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11. Latin America
5.11.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.11.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.3. Brazil
5.11.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.4. Mexico
5.11.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.5. Argentina
5.11.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.11.6. Colombia
5.11.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12. Middle East and Africa
5.12.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.12.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12.3. South Africa
5.12.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12.4. Saudi Arabia
5.12.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
5.12.5. UAE
5.12.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)

Chapter 6. Anesthesia and Respiratory Devices Market - Competitive Analysis
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2018
6.4. Public Companies
6.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.4.2. Company market share/ranking, by region
6.4.3. Competitive dashboard analysis
6.4.3.1. Market differentiators
6.4.3.2. Synergy analysis: Major deals & strategic alliances
6.5. Private Companies
6.5.1. List of key emerging companies/technology disruptors/innovators
6.5.2. Funding outlook (Optional)
6.5.3. Regional network map
6.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.6. Supplier Ranking
6.7. Key Companies Profiled
6.7.1. GE Healthcare
6.7.1.1. Company overview
6.7.1.2. Financial performance
6.7.1.3. Product benchmarking
6.7.1.4. Strategic initiatives
6.7.2. Medtronic Plc
6.7.2.1. Company overview
6.7.2.2. Financial performance
6.7.2.3. Product benchmarking
6.7.2.4. Strategic initiatives
6.7.3. Teleflex Incorporated
6.7.3.1. Company overview
6.7.3.2. Financial performance
6.7.3.3. Product benchmarking
6.7.3.4. Strategic initiatives
6.7.4. Philips Healthcare
6.7.4.1. Company overview
6.7.4.2. Financial performance
6.7.4.3. Product benchmarking
6.7.4.4. Strategic initiatives
6.7.5. Drägerwerk AG & Co. KGaA
6.7.5.1. Company overview
6.7.5.2. Financial performance
6.7.5.3. Product benchmarking
6.7.5.4. Strategic initiatives
6.7.6. Getinge AB
6.7.6.1. Company overview
6.7.6.2. Financial performance
6.7.6.3. Product benchmarking
6.7.6.4. Strategic initiatives
6.7.7. Smiths Group Plc
6.7.7.1. Company overview
6.7.7.2. Financial performance
6.7.7.3. Product benchmarking
6.7.7.4. Strategic initiatives
6.7.8. Fisher & Paykel Healthcare Limited
6.7.8.1. Company overview
6.7.8.2. Financial performance
6.7.8.3. Product benchmarking
6.7.8.4. Strategic initiatives
6.7.9. Masimo Corporation
6.7.9.1. Company overview
6.7.9.2. Financial performance
6.7.9.3. Product benchmarking
6.7.9.4. Strategic initiatives
6.7.10. B. Braun Melsungen AG
6.7.10.1. Company overview
6.7.10.2. Financial performance
6.7.10.3. Product benchmarking
6.7.10.4. Strategic initiatives
6.7.11. ResMed
6.7.11.1. Company overview
6.7.11.2. Financial performance
6.7.11.3. Product benchmarking
6.7.11.4. Strategic initiatives
6.7.12. Charts Industries
6.7.12.1. Company overview
6.7.12.2. Financial performance
6.7.12.3. Product benchmarking
6.7.12.4. Strategic initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • GE Healthcare
  • Medtronic Plc
  • Teleflex Incorporated
  • Philips Healthcare
  • Drägerwerk AG & Co. KGaA
  • Getinge AB
  • Smiths Group Plc
  • Fisher & Paykel Healthcare Limited
  • Masimo Corporation
  • B. Braun Melsungen AG
  • ResMed
  • Charts Industries
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4773497
Adroll
adroll